PureTech Founded Entity Karuna Therapeutics Announces U.S. F

Prescription Drug User Fee Act action date is September 26, 2024


If approved, KarXT would represent the first new pharmacological approach to treating schizophrenia in several decades


The...

Related Keywords

Boston , Massachusetts , United States , Gordon Lavigne , Karuna Therapeutics Inc , Securities Exchange , Exchange Commission , Nasdaq , Schizophrenia Psychosis Action Alliance , Puretech Health , Drug Administration , Twitter , Founded Entity , Karuna Therapeutics , New Drug Application , Prescription Drug User Fee Act , Drug Administration Accepts New Application , Drug User Fee Act , Bill Meury , Psychosis Action , Negative Syndrome Scale , Rishi Kakar , Segal Trials , Securities Act , Securities Exchange Act , Annual Report , Founded Entities , Private Securities Litigation Reform Act , Markets ,